...
首页> 外文期刊>Plastic and reconstructive surgery >Simultaneous bilateral breast reconstruction with autologous tissue transfer after the removal of injectable artificial materials: a 12-year experience.
【24h】

Simultaneous bilateral breast reconstruction with autologous tissue transfer after the removal of injectable artificial materials: a 12-year experience.

机译:去除可注射的人工材料后,自体组织转移同时进行双侧乳房再造:12年的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Over the years, breast augmentation with injectable artificial materials has presented significant clinical and social problems, particularly in Japan, because of later complications. The authors have used autologous tissue to treat patients who want not only to have these materials removed but also to maintain breast contour. The purpose of this study was to review the clinical outcome of the authors' reconstruction procedures retrospectively. METHODS: A total of 38 breasts in 19 consecutive cases treated between 1991 and 2002 were reviewed. The patients were all women, ranging in age from 41 to 70 years old (mean age, 53.4 years). The average period from injection to reconstruction was 26.5 years. After removal of the injected materials, both breasts were simultaneously reaugmented with deepithelialized rectus abdominis flaps. The incidence of associated complications was investigated. RESULTS: The 38 flaps consisted of 31 free transverse rectus abdominis musculocutaneous flaps, five pedicled transverse rectus abdominis musculocutaneous flaps, and two pedicled vertical rectus abdominis musculocutaneous flaps. Three flaps with total necrosis (7.9 percent) because of venous thrombosis were found in two cases. Partial flap necrosis was observed in six flaps (15.8 percent). Hematoma requiring a surgical procedure occurred in one case (5.3 percent). Negligible abdominal bulging requiring no additional procedure was found in seven cases (36.8 percent). CONCLUSIONS: The complication rate seemed to be relatively high compared with that for breast reconstruction after mastectomy. Nevertheless, autologous tissue transfer may be one of the ideal procedures for breast reaugmentation after the removal of injectable materials, because affected patients prefer not to undergo reaugmentation with other artificial materials.
机译:背景:多年来,使用可注射的人工材料隆胸已经出现了重大的临床和社会问题,尤其是在日本,因为后来出现了并发症。作者使用自体组织来治疗不仅要去除这些材料而且还要保持乳房轮廓的患者。这项研究的目的是回顾性地回顾作者重建程序的临床结果。方法:回顾性分析了1991年至2002年间连续治疗的19例病例中的38例乳房。患者均为女性,年龄在41至70岁之间(平均年龄为53.4岁)。从注射到重建的平均时间为26.5年。取出注射物后,同时用深层上腹直肌皮瓣再补乳。调查了相关并发症的发生率。结果:38个皮瓣由31个腹直肌横断肌皮瓣,5个带蒂腹直肌横断肌皮瓣和2个带蒂腹直肌直肌横断肌皮瓣组成。在两个病例中,发现三个由于静脉血栓形成的皮瓣完全坏死(7.9%)。在六个皮瓣中观察到部分皮瓣坏死(15.8%)。需要手术的血肿发生在一个病例中(5.3%)。在7例中发现了可以忽略不计的无需额外手术的腹部膨出(36.8%)。结论:与乳房切除术后乳房重建相比,并发症发生率似乎相对较高。尽管如此,自体组织转移可能是去除可注射材料后进行乳房再造的理想方法之一,因为受影响的患者更愿意不进行其他人工材料的造乳房。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号